Delineating the RAS Conformational Landscape.

Abstract excerpt

Mutations in RAS isoforms (KRAS, NRAS, and HRAS) are among the most frequent oncogenic alterations in many cancers, making these proteins high priority therapeutic targets. Effectively targeting RAS isoforms requires an exact understanding of their active, inactive, and druggable conformations. However, there is no structural catalog of RAS conformations to guide therapeutic targeting or examining the structural...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Guanosine Triphosphate
• Share to Mutation
• Share to Protein Conformation